Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „received“
Suchtreffer
Begriffe & Kennungen
Bosulif · 4.8 · A total of 55 paediatric patients ≥ 1 year of age received at least 1 dose of bosutinib in the Phase I/II, mul
Eintrag öffnenBrinavess · 4.5 · Vernakalant must not be administered in patients who received intravenous AADs (class I and III) within 4 hour
Eintrag öffnenBrineura · 4.8 · The adverse reactions described in this section were evaluated in 38 patients with CLN2 disease who received a
Eintrag öffnenCabometyx · 4.8 · Description of selected adverse reactions Data for the following reactions are based on patients who received
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Adult patients In clinical studies, 1,865 adult individuals received single or multiple doses of caspofungin:
Eintrag öffnenCatiolanze · 4.8 · Long term safety data are available from a Phase 3 study in which 118 patients received Catiolanze at least fo
Eintrag öffnenCayston · 4.8 · In the two Phase 3 placebo-controlled clinical studies where patients received Cayston for 28 days, the most f
Eintrag öffnenCervarix · 4.5 · In all clinical trials individuals who had received immunoglobulin or blood-derived products within 3 months p
Eintrag öffnenCervarix · 4.5 · In clinical studies, approximately 60% of women who received Cervarix used hormonal contraceptives. There is n
Eintrag öffnenCholestagel · 4.5 · There have been very rare reports of reduced phenytoin levels in patients who have received Cholestagel admini
Eintrag öffnenCoAprovel · 4.8 · Among 898 hypertensive patients who received various doses of irbesartan/hydrochlorothiazide (range: 37.5 mg/6
Eintrag öffnenCoAprovel · 4.8 · Among 898 hypertensive patients who received various doses of irbesartan/hydrochlorothiazide (range: 37.5 mg/6
Eintrag öffnenCoAprovel · 4.8 · Among 898 hypertensive patients who received various doses of irbesartan/hydrochlorothiazide (range: 37.5 mg/6
Eintrag öffnenCoAprovel · 4.8 · Among 898 hypertensive patients who received various doses of irbesartan/hydrochlorothiazide (range: 37.5 mg/6
Eintrag öffnenCoAprovel · 4.8 · Among 898 hypertensive patients who received various doses of irbesartan/hydrochlorothiazide (range: 37.5 mg/6
Eintrag öffnenColumvi · 4.8 · 21 Colitis Colitis (Grade 4) was reported in 1 patient (0.7%) who received Columvi monotherapy, with time to o
Eintrag öffnenColumvi · 4.8 · Among the 11 patients who experienced Grade ≥ 2 tumour flare, 2 patients (18.2%) received analgesics, 6 patien
Eintrag öffnenColumvi · 4.8 · Among the 22 patients who experienced Grade 2 CRS after Columvi, 16 (72.7%) received tocilizumab, 15 (68.2%)
Eintrag öffnenColumvi · 4.8 · Among the 25 patients who experienced Grade 2 CRS after Columvi, 22 (88.0%) received tocilizumab, 15 (60.0%)
Eintrag öffnenColumvi · 4.8 · Any grade CRS (by ASTCT criteria) occurred in 44.2% of patients who received Columvi with gemcitabine and oxal
Eintrag öffnen